These findings indicate that in advanced BC, the levels of CD4+ and CD8+ cells decrease, negatively affecting disease prognosis, which is consistent with our observations that activated memory CD4+ cells, CD8+ T cells, and plasma cells decreased with the increase of cancer stage and lymph node metastasis. The gene discussed is CD8A; the disease is breast cancer.